Gene · 114907
Papers2,920
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,920
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Elevated circulating GDF11 and its role in age-related sarcopenia: insights from clinical, transcriptomic, and in vitro analyses. | Front Aging | 2026 | 41822302 | PubTator, text mining | PubMed |
| A Systematic Review and User Reference of Phenotypic and Molecular Characteristics of Dexamethasone-Mediated C2C12 Muscle Atrophy. | J Cachexia Sarcopenia Muscle | 2026 | 41821373 | PubTator, text mining | PubMed |
| Chronic inflammation as a driving factor for sarcopenia: an update on pathophysiology and future therapeutic targets. | Front Pharmacol | 2026 | 41808874 | PubTator, text mining | PubMed |
| Beyond muscle weakness: pathogenesis of sepsis-induced myopathy and its management. | Open Med (Wars) | 2026 | 41798907 | PubTator, text mining | PubMed |
| Repeat-rich RNA guides repetitive genomic elements into biomolecular condensates for heterochromatin organization and muscle integrity. | Nucleic Acids Res | 2026 | 41797541 | PubTator, text mining | PubMed |
| Compounds identified by screening that inhibit the activity of transcription factor FOXO1/3a suppress dexamethasone-induced atrogin1 expression in C2C12 myoblasts. | Biosci Biotechnol Biochem | 2026 | 41790122 | PubTator, text mining | PubMed |
| The gut as a central hub for multi-organ crosstalk in aging. | Cell Mol Life Sci | 2026 | 41787017 | PubTator, text mining | PubMed |
| Gut Microbiota Has the Potential to Improve Sarcopenic Obesity in Menopausal Women by Regulating Estrogen. | Int J Womens Health | 2026 | 41783752 | PubTator, text mining | PubMed |
| Vitamin D deficiency and disease conditions relevant to: Orthopaedic translation. | J Orthop Translat | 2026 | 41777703 | PubTator, text mining | PubMed |
| The therapeutic potential of Myoki, a novel peptide in muscle atrophy: mechanisms and applications. | Front Pharmacol | 2026 | 41769692 | PubTator, text mining | PubMed |
| Endoplasmic reticulum stress in skeletal muscle dysfunction of type 2 diabetes: mechanisms and therapeutic implications. | Front Endocrinol (Lausanne) | 2026 | 41767393 | PubTator, text mining | PubMed |
| Vitamin D-Mediated Immunoregulation in Degenerative Diseases: Insights into Cardiovascular, Neurodegenerative and Musculoskeletal Disorders. | Nutrients | 2026 | 41754146 | PubTator, text mining | PubMed |
| Therapeutic Potential of Polydatin Against Cancer Cachexia by Regulating the STAT3 Signaling Pathway. | Nutrients | 2026 | 41754120 | PubTator, text mining | PubMed |
| Alcohol Consumption During Muscle Disuse Causes Differential Signaling Responses in a Muscle-Specific Manner in Mice. | Int J Mol Sci | 2026 | 41752005 | PubTator, text mining | PubMed |
| NF-κB Signaling as a Central Driver of Cancer Cachexia. | Cancers (Basel) | 2026 | 41749811 | PubTator, text mining | PubMed |
| Exercise preconditioning prevents immobilization-induced skeletal muscle atrophy by activating Prmt1-p38/ATF2-Sesn1 signaling axis in C57BL/6J mice. | Sports Med Health Sci | 2026 | 41737591 | PubTator, text mining | PubMed |
| Interactive effects of dietary crude protein reduction and resistant starch inclusion on growth performance and cecal microbial fermentation in broiler chickens. | Poult Sci | 2026 | 41734672 | PubTator, text mining | PubMed |
| Transcriptomic suppression of immune and ECM stability in skeletal muscle of patients with chronic kidney disease. | PLoS One | 2026 | 41734178 | PubTator, text mining | PubMed |
| Mitochondrial-derived peptides MOTS-c and humanin attenuate dexamethasone-induced atrophy in human skeletal muscle cells. | Physiol Rep | 2026 | 41732124 | PubTator, text mining | PubMed |
| Advances in electrical stimulation-based therapeutic technologies for sarcopenia prevention and treatment. | Bioact Mater | 2026 | 41727275 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/114907/papers?page=3